Total Payments
$431,029
2024 Payments
$27,938
Companies
73
Transactions
1,937
Medicare Patients
4,937
Medicare Billing
$652,808
Payment Breakdown by Category
Other$372,024 (86.3%)
Food & Beverage$37,575 (8.7%)
Consulting$13,379 (3.1%)
Travel$7,139 (1.7%)
Education$478.08 (0.1%)
Research$375.00 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $371,864 | 262 | 86.3% |
| Food and Beverage | $37,575 | 1,609 | 8.7% |
| Consulting Fee | $13,379 | 7 | 3.1% |
| Travel and Lodging | $7,139 | 41 | 1.7% |
| Education | $478.08 | 14 | 0.1% |
| Unspecified | $375.00 | 1 | 0.1% |
| Long term medical supply or device loan | $159.93 | 2 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Payments by Type
General
$430,654
1,936 transactions
Research
$375.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $169,397 | 262 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97,316 | 242 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $71,863 | 165 | $0 (2023) |
| Lilly USA, LLC | $54,704 | 237 | $0 (2024) |
| ABBVIE INC. | $17,290 | 53 | $0 (2024) |
| Dexcom, Inc. | $2,929 | 89 | $0 (2024) |
| Novo Nordisk Inc | $1,987 | 119 | $0 (2024) |
| Amgen Inc. | $1,487 | 65 | $0 (2024) |
| Abbott Laboratories | $1,461 | 127 | $0 (2024) |
| Mannkind Corporation | $1,235 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,938 | 220 | Lilly USA, LLC ($12,695) |
| 2023 | $21,131 | 206 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,460) |
| 2022 | $41,157 | 242 | SANOFI-AVENTIS U.S. LLC ($20,250) |
| 2021 | $62,613 | 252 | SANOFI-AVENTIS U.S. LLC ($33,944) |
| 2020 | $36,807 | 177 | Lilly USA, LLC ($12,382) |
| 2019 | $59,589 | 254 | SANOFI-AVENTIS U.S. LLC ($20,104) |
| 2018 | $64,044 | 274 | SANOFI-AVENTIS U.S. LLC ($30,309) |
| 2017 | $117,750 | 312 | SANOFI-AVENTIS U.S. LLC ($54,726) |
All Payment Transactions
1,937 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $34.33 | General |
| 12/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/10/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $20.75 | General |
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $49.86 | General |
| Category: Endocrinology | ||||||
| 11/28/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/23/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/21/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/19/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $131.68 | General |
| Category: Automated insulin delivery system | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/11/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Roche Diabetes Care Platform 2.1 Design Validation Study | Roche Diabetes Care, Inc. | $375.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,285 | 2,111 | $351,037 | $174,879 |
| 2022 | 10 | 1,106 | 2,067 | $333,675 | $174,425 |
| 2021 | 12 | 1,209 | 1,935 | $318,010 | $170,585 |
| 2020 | 8 | 1,337 | 1,854 | $283,088 | $132,919 |
Total Patients
4,937
Total Services
7,967
Medicare Billing
$652,808
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 707 | 1,135 | $218,044 | $106,047 | 48.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 398 | $45,667 | $26,311 | 57.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $23,732 | $8,803 | 37.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 81 | $11,916 | $8,054 | 67.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 50 | $13,470 | $7,289 | 54.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 120 | 159 | $8,022 | $4,362 | 54.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 51 | 53 | $6,621 | $4,138 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 65 | $9,215 | $4,001 | 43.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $6,030 | $3,388 | 56.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 26 | 26 | $7,020 | $2,126 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 43 | $1,301 | $361.20 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 661 | 1,275 | $229,562 | $120,011 | 52.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 339 | $36,612 | $20,219 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $18,825 | $7,821 | 41.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 58 | 72 | $7,920 | $5,189 | 65.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 76 | $10,260 | $4,538 | 44.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 26 | $5,960 | $4,330 | 72.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 42 | $5,460 | $3,601 | 65.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 83 | 126 | $6,300 | $3,459 | 54.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 36 | 36 | $9,720 | $3,443 | 35.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $3,056 | $1,814 | 59.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 695 | 1,217 | $219,350 | $120,269 | 54.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 178 | 196 | $21,560 | $13,163 | 61.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 103 | $13,390 | $9,029 | 67.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 124 | $13,392 | $7,571 | 56.5% |
About Dr. Daniel So, M.D
Dr. Daniel So, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Arlington Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023167004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel So, M.D has received a total of $431,029 in payments from pharmaceutical and medical device companies, with $27,938 received in 2024. These payments were reported across 1,937 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($371,864).
As a Medicare-enrolled provider, So has provided services to 4,937 Medicare beneficiaries, totaling 7,967 services with total Medicare billing of $652,808. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Arlington Heights, IL
- Active Since 01/09/2007
- Last Updated 04/28/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1023167004
Products in Payments
- JARDIANCE (Drug) $148,795
- FARXIGA (Drug) $68,538
- SOLIQUA (Drug) $49,626
- TOUJEO (Drug) $41,934
- SOLIQUA 100/33 (Biological) $39,332
- TOUJEO (Biological) $24,250
- SOLIQUA 100/33 (Drug) $12,975
- Synthroid (Drug) $12,037
- SYNTHROID (Drug) $5,051
- BYDUREON (Drug) $3,250
- Dexcom G6 Transmitter (Medical Supply) $2,278
- AFREZZA (Drug) $1,235
- UNITHROID (Drug) $844.89
- TRULICITY (Drug) $840.89
- EVENITY (Biological) $725.52
- Korlym (Drug) $722.30
- Ozempic (Drug) $717.45
- INVOKANA (Drug) $649.81
- MOUNJARO (Drug) $627.16
- TRADJENTA (Drug) $625.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Arlington Heights
Dr. Luis Soruco, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $130,203
Endocrinology, Diabetes & Metabolism $130,203
Dr. Mario Chan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $31,415
Endocrinology, Diabetes & Metabolism $31,415
Paraskevi Sapountzi, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $19,168
Endocrinology, Diabetes & Metabolism $19,168
Zubair Ilyas, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $12,208
Endocrinology, Diabetes & Metabolism $12,208
Elena Barengolts
Endocrinology, Diabetes & Metabolism — Payments: $7,748
Endocrinology, Diabetes & Metabolism $7,748
Maria Justina Villano, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $971.90
Endocrinology, Diabetes & Metabolism $971.90